Blog / Events / Videos / Women in COG

22 Dec 2021

“COVID must not distract us from the fight for equality” – in conversation with Sir Jeremy Farrar

In the final instalment of our Women in COG series for 2021,  Professor Sharon Peacock, Executive Director and Chair of COG-UK, and Sir Jeremy Farrar, Director of the Wellcome Trust, discussed why diversity and inclusion must return to the top of the agenda.

Watch the full recording of the event from the 16th December, 2021, or read our summary of the conversation below.


“The idea that in 2021 things are better, and therefore okay, is the problem,” explains Jeremy Farrar, Director of the Wellcome Trust and one of the nation’s most trusted scientific voices.

“The challenges women and minority groups face in science today will be different to the challenges faced 20 or 30 years ago. It’s what it is today that matters, not whether it was worse in history.”

What is happening today is alarming. The challenges two years of pandemic have created for women, already less than 30% of the world’s researchers before COVID-19 struck, are estimated to have set back progress on gender equality by a generation.

And on racial equality, Farrar is candid. Despite a flurry of activity following the shock of George Floyd’s murder in May 2020, he believes the world has become distracted by the pandemic, himself included.

“I pay tribute to people who pushed Wellcome to becoming an anti-racist organization. Not just about equality and inclusion, but actually actively anti-racist…The danger is, as time goes on, and other issues come to the surface, that your shock of that moment wanes to some degree. It becomes the horrible phrase of ‘business as usual’.

“I almost didn’t realise I was doing that, but it did. And somebody called me up on that and said: ‘A year ago, this was the number one priority. You haven’t spoken about being an anti-racist organisation for weeks.’ And they were right,” he recalls.

“If you don’t use those moments to change the way you do things, you pay attention for a while, then it drifts away. Other things happen and that moment is lost. That is very, very dangerous.”

Many would perhaps excuse Farrar some distraction. He is the head of the world’s second largest independent charitable foundation – during a global pandemic. Until he left the role in November, Farrar was also a key advisor to the UK Government’s Scientific Advisory Group for Emergencies (SAGE), under unrelenting pressure at the heart of the country’s public health response.

But, he says, that’s exactly why a revolution in how we think and behave is even more important.

“This has to be embedded within our thinking and very importantly, our actions – the way we communicate, the way we do everything. Because it’s us. It’s not us when we’re feeling rested and well, it’s us all the time. That is the challenge – making it us, rather than something we do.”

Part of the answer, as Farrar sees it, is for leaders like him to have “an absolute responsibility” for creating an environment “by which calling out, done in the right way, is encouraged and facilitated and let happen.”

Another is listening: “There’s a Vietnamese phrase ‘when you’re in conversation with somebody else, it’s probably better to speak less than half the time’,” says Farrar, quoting a proverb picked up during his nearly two decades heading up a clinical research unit in Ho Chi Minh City.

But equality also requires a societal shift towards more opportunity in education, or “the ability to let people have a second chance in education”, as Farrar previously described it in an interview for the BBC’s Desert Island Discs. It’s a point Sharon Peacock has spoken out about too.

Both scientists had a route into research that was far from straightforward. Farrar got there despite having to re-sit his A levels after failing them; Peacock earned her grades at night school and went to university as a mature student after hounding the admissions tutor.

“Social mobility through education and being able to get access to education so that you can do what you want to in your life is a really key enabler. Not only giving people the opportunity to have an education, but also having the role models,” says Peacock.

“Back then, I didn’t know anybody who had gone to university, and we didn’t have many books in the house, and it’s having that very early influence to help you think about an alternative life for yourself that’s so important.”

Farrar agrees: “I have taken recently to write to people that I have come across in my career to thank them. I realise that some of them are getting to be of an age where I might not see them again”.

The letter-writing is an approach Peacock shares. One of hers went to the admissions tutor who let her into the University of Southampton despite her grades.

“Very few unis accepted mature students back then. He must have seen something in me,” she recalls.

“A small act of kindness can completely change people’s lives.”

Sir Jeremy Farrar

Jeremy Farrar is Director of the Wellcome Trust – the world’s second largest independent charitable foundation that exists to improve human health through research.  Jeremy is a clinician scientist who before joining Wellcome in 2013 was, for eighteen years, Director of the Clinical Research Unit at the Hospital for Tropical Diseases in Viet Nam, where his research interests were in global health with a focus on emerging infectious diseases. He was named 12th in the Fortune list of 50 World’s Greatest Leaders in 2015 and was awarded the Memorial Medal and Ho Chi Minh City Medal from the Government of Viet Nam. In 2018 he was recognised as the President Jimmy and Rosalynn Carter Humanitarian of the Year. Jeremy was knighted in the Queen’s 2019 New Year Honours for services to global health and awarded the Order of the Rising Sun, Gold Rays with Neck Ribbon by the Government of Japan in recognition of contribution to global health. He is a Fellow of the Academy of Medical Sciences UK, European Molecular Biology Organisation (EMBO), the National Academies USA and a Fellow of The Royal Society.


Professor Sharon Peacock

Sharon Peacock is a clinician scientist who has worked in academic clinical microbiology across the United Kingdom and in Southeast Asia for the last 25 years, including 7 years living and working in Thailand and Cambodia. She is currently Professor of Public Health and Microbiology in the Department of Medicine, University of Cambridge; Executive Director of the COVID-19 Genomics UK (COG-UK) consortium; and a Non-Executive Director on the board of Cambridge University Hospitals NHS Foundation Trust.  Sharon has built her scientific expertise around pathogen genomics, antimicrobial resistance, and a range of tropical diseases. She has raised around £60 million pounds in science funding, published more than 500 peer-reviewed papers, and has trained a generation of scientists in the UK and elsewhere. She has sought to influence both practice and policy relating to the use of pathogen genomics in diagnostic and public health over the last decade. Sharon was instrumental in the development of COG-UK, which was formed in April 2020 to provide SARS-CoV-2 genomes to UK public health agencies, and which has since generated over a million SARS-CoV-2 genomes.  Sharon is a Fellow of the Academy of Medical Sciences, a Fellow of the American Academy of Microbiology, and an elected Member of the European Molecular Biology Organization (EMBO). In 2015, She received a CBE for services to medical microbiology, and in 2018 she won the Unilever Colworth Prize for her outstanding contribution to translational microbiology.


About Women in COG

The COG-UK consortium has over 500 members with a range of scientific and business expertise in genomics, bioinformatics, operations clinical science and public health. Women in COG is a supportive network to share experience and knowledge and to promote science careers in women and girls.

This was an event in our series of monthly lunchtime Women in COG events and everyone (regardless of gender) is welcome to attend. The events will feature a conversation with a guest or consortium member followed by an informal Q&A.

Check out our past and upcoming Women in COG events.

COVID-19 Genomics UK (COG-UK)

The COVID-19 Genomics UK (COG-UK) consortium works in partnership to harness the power of SARS-CoV-2 genomics in the fight against COVID-19.

Led by Professor Sharon Peacock of the University of Cambridge, COG-UK is made up of an innovative collaboration of NHS organisations, the four public health agencies of the UK, the Wellcome Sanger Institute and sixteen academic partners. A full list of collaborators can be found here.

The COVID-19 pandemic, caused by SARS-CoV-2, represents a major threat to health. The COG-UK consortium was formed in March 2020 to deliver SARS-CoV-2 genome sequencing and analysis to inform public health policy and to support the establishment of a national pathogen sequencing service, with sequence data now predominantly generated by the Wellcome Sanger Institute and the Public Health Agencies.

SARS-CoV-2 genome sequencing and analysis plays a key role in the COVID-19 public health response by enabling the identification, tracking and analysis of variants of concern, and by informing the design of vaccines and therapeutics. COG-UK works collaboratively to deliver world-class research on pathogen sequencing and analysis, maximise the value of genomic data by ensuring fair access and data linkage, and provide a training programme to enable equity in global sequencing.